 |
|
|
Dr. Corey Goodman 1997 Gairdner Laureate in neuroscience. Founder of two biotechnology companies. Presently, President, Biotherapeutics and Bioinnovation Center, Pfizer Inc. San Francisco, California. See: www.pfizer.com/about/leadership_and_structure/leadership_executives_goodman.jsp |
 |
| Dr. Michael Hayden Director of the Center for Molecular Medicine and Therapeutics, UBC. He focuses his research primarily on genetic diseases, including genetics of lipoprotein disorders, Huntington's disease, predictive and personalized medicine. His group has identified 10 disease-causing genes. He is the recipient of numerous awards including CIHR Canada's Health Researcher of the Year for 2008 and was one of the five finalists of the Globe and Mail's Nation Builder competition in 2008. See www.gairdner.org/aboutus~2/medicala/michaelhay |
 |
 Panel Moderator Mark Lievonen President, Sanofi Pasteur Limited and a member of the York University Board of Governors. |
 |
Panelists Dr. Alan Bernstein President Emeritus of the Canadian Institutes of Health Research and presently Executive Director, Global HIV Vaccine Enterprise, New York. Gairdner Wightman Award Laureate, 2008. See www.gairdner.org/awards/awardees2/2008/2008awarde/alanbernst |
 |
| Susan Smith Founder, Former President and CEO of RBC Ventures, Toronto, Board of Directors, MaRS. See www.marsdd.com/mars/About-MaRS/MaRS-Leadership-Team/smith-s.html |
 |
| Dr. Richard Gold McGill University, Faculty of Law. Founding director of the Centre for Intellectual Property Policy. He teaches in the area of intellectual property and common law property at McGill University's Faculty of Law. His research centres on understanding the links between innovation, intellectual property and development, translating research into policy. See people.mcgill.ca/richard.gold2/ |
 |
